Unijules.com

Product & Method Development PDF Print E-mail

" Serving an industry that is rapidly chaning means keeping our focus on the future".

UNIJULES has assembled a team of researchers, scientists & technical personnel with competence and experience to provide the following range of services :Image

  • Development & Validation of Formation.
  • Analytical Development - Customized testing to meet our client specifications.
  • Organized, time-valued and cost effective testing methods.
  • Performing and/or monitoring stability testings based on ICH guidelines.

  


 SPECIALISED PRODUCTS:

"Providing a distinct market advantage and immense value addition."

 The following specific formulations are offered:Image

  • Taste  and Odor Masked Formulations.
  • Immediate Release Stabilized Multi-component Formulations.
  • Sustained / Enteric / Dual Release Formulations.
  • Stability & Bio-Availability Enhancement in Premixes / Granulates / formulations.
  • Dispersible / Mouth Dissolving Tablets and their RC Granules.
  • Herbal single & multi-components pre-mixes, granules and multiparticulates.
  • Non-Pareil Seeds& other preprocessed recipients.
  • Mother Tinctures and classical herbals.
  • Hormonal Injections and Iron Dextran.
  • Contrast Media Anionic and Non Ionic.
Additionally, the company has the experience & ability to manufacture and supply large volumes of standard and customised finished formulations under different labels & brans names. This large volume capacity allows us to offer our customers products of consistent quality with reduced lead-times.
 
< Prev   Next >

UNIQUE INNOVATIONS

Other Links...

 



You are here  :Home arrow Services arrow Regulatory Affairs
Unijules Life Sciences Limited is proposing – subject to receipt of requisite approvals, market conditions and other considerations - a public issue of its equity shares. The Draft Red Herring Prospectus has been filed by the Company with SEBI and is available on SEBI website at www.sebi.gov.in as well as on the Book Running Lead Managers website www.rathi.com.

Investors should note that an investment in equity shares involves a high degree of risk and for details relating to the same, please refer to the section titled ‘Risk Factors’ of the DRHP.